Cladribine modifies functional properties of microglia

L. Ø. Jørgensen, K. H. Hyrlov, M. L. Elkjaer, Anna Borch Weber, A. E. Pedersen, Fex Svenningsen, Z. Illes*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

23 Downloads (Pure)

Abstract

Cladribine (CdA), an oral prodrug approved for the treatment of relapsing multiple sclerosis, selectively depletes lymphocytes. CdA passes the blood–brain barrier, suggesting a potential effect on central nervous system (CNS) resident cells. We examined if CdA modifies the phenotype and function of naive and activated primary mouse microglia, when applied in the concentrations 0·1–1 μM that putatively overlap human cerebrospinal fluid (CSF) concentrations. Primary microglia cultures without stimulation or in the presence of proinflammatory lipopolysaccharide (LPS) or anti-inflammatory interleukin (IL)-4 were treated with different concentrations of CdA for 24 h. Viability was assessed by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Phagocytotic ability and morphology were examined by flow cytometry and random migration using IncuCyte Zoom and TrackMate. Change in gene expression was examined by quantitative polymerase chain reaction (qPCR) and protein secretion by Meso Scale Discovery. We found that LPS and IL-4 up-regulated deoxycytidine kinase (DCK) expression. Only activated microglia were affected by CdA, and this was unrelated to viability. CdA 0·1–1 μM significantly reduced granularity, phagocytotic ability and random migration of activated microglia. CdA 10 μM increased the IL-4-induced gene expression of arginase 1 (Arg1) and LPS-induced expression of IL-1β, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS) and Arg1, but protein secretion remained unaffected. CdA 10 μM potentiated the increased expression of anti-inflammatory TNF receptor 2 (TNF-R2) but not TNF-R1 induced by LPS. This suggests that microglia acquire a less activated phenotype when treated with 0·1–1 μM CdA that putatively overlaps human CSF concentrations. This may be related to the up-regulated gene expression of DCK upon activation, and suggests a potential alternative mechanism of CdA with direct effect on CNS resident cells.

Original languageEnglish
JournalClinical and Experimental Immunology
Volume201
Issue number3
Pages (from-to)328-340
ISSN0009-9104
DOIs
Publication statusPublished - Sep 2020

Keywords

  • cladribine
  • deoxycytidine kinase
  • microglia
  • migration
  • multiple sclerosis
  • phagocytosis
  • viability

Fingerprint Dive into the research topics of 'Cladribine modifies functional properties of microglia'. Together they form a unique fingerprint.

Cite this